AI processes could detect early-stage lung cancer from unstructured medical notes Clinithink – a company that has developed artificial intelligence (AI) capable of understanding unstructured medical…
As one of the world’s largest biopharmaceutical companies, AstraZeneca pushes the boundaries of science to deliver life-changing medicines that create enduring value for patients and society. To accelerate growth through innovation, the company is expanding its use of data science and artificial intelligence (AI) across the business to improve patient outcomes.
AstraZeneca has been on…
Illumina signed up for a new collaboration with AstraZeneca with the goal of aligning their artificial intelligence development efforts in a way that combines genomic analysis and drug discovery re | The project will explore whether applying AI to DNA and other omics sequencing data can increase their returns in successful biological targets and promising drug…
Aims to improve efficiency of pharma pipelines by leveraging industry-leading ability to identify genetic variants that contribute to human disease SAN DIEGO , Oct. 11, 2022 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a strategic research collaboration with AstraZeneca, a global, science-led…